We're looking forward to being a part of Cancer52's #BigCancer52Conversation today. Our CEO, Fiona Hazell Fiona Hazell, will be speaking about our manifesto, which calls on the next UK government to do more to save and improve the lives of leukaemia patients. 🪧

Looking forward to the panel discussion at #Cancer52’s Big Conversation today when I’ll be speaking with Chris Carrigan, #UseMyData, on The Power of Data !!! #cholangiocarcinoma #livertwitter

A key part of the #BigCancer52Conversation are the marketplace sessions – expert-led tables to facilitate knowledge and collaboration. Our panel summarises the main themes heard today. The Eve Appeal Ovacome - the ovarian cancer support charity Action Kidney Cancer Melanoma Focus UK Solving Kids' Cancer UK 🎗 Young Lives vs Cancer

Thanks Sharon Deveson Kell from Action Kidney Cancer for capturing the discussions on improving access to clinical trials at Cancer52 Big Cancer Conversation: more awareness, better information, ensuring that all patients have timely access potentially suitable trials wherever they are

Great to meet so many potential collaborators at Cancer52’s #BigCancer52Conversation LifeArc Wellbeing of Women Research@TheBrainTumourCharity

(What) a year in politics! Discussions on what might lie ahead get underway at #BigCancer52Conversation today. #cholangiocarcinoma #bileductcancer #AMMF #cancer52org

Thank you Cancer52 for giving us the opportunity to be part of the marketplace sessions. #BigCancer52Conversation #kidneycancer

We would like to say a huge thank all the panellists, topic experts and attendees who made the #BigCancer52Conversation such a success yesterday – it was fantastic to see so much collaboration and drive to make a difference to those affected by rare & less common cancers

Always great to get together at Cancer52 #BigCancer52Conversation with other charities representing rare and less common cancers. Lots of great conversations about how we can work together to get rare and less common cancers up the agenda!

Cancer52, along with many other cancer charities, are calling on all political parties to commit to supporting a long-term cancer strategy to improve cancer outcomes in England. People affected by rare & less common cancer need a plan #OneCancerVoice

Great to join such an inspirational bunch, receiving Gilead's and Kite's #LookAndYouWillCUs grant awards, and to see the thought and priority that’s being given to health inequalities in rare and less common cancers.

A key role of Cancer52 is partnership so Cancer52 CEO, Jane Lyons was delighted to take part in this video on the importance of collaboration in the UK’s life sciences sector.

Welcome Wes Streeting MP to your new role. A note from the 47% of people with cancer who have a rare or less common cancer. As the spokesperson for the 115 charities in this sector we wrote up what’s needed. Our manifesto is here cancer52.org.uk/single-post/ca… and we’d love to talk!

We welcome legislation, confirmed in the #KingsSpeech today, to raise the age on the sale of cigarettes and limit the sale and marketing of vapes. Smoking is often associated with causing lung cancer, but actually many more rare and less common cancers are linked to tobacco use.

The Participant Panel at Genomics England is recruiting for a new Chair. Applications close on 30 September. Apply here: ow.ly/7oPr50ST0Vy

Cancer52 is one of the health and care charities to sign National Voices' joint letter to Wes Streeting MP 👇

We're delighted to announce Chris Walden as Cancer52’s new CEO! Bringing fantastic experience from both membership organisations and cancer charities, Chris’s commitment and vision will advance Cancer52’s mission as the common voice for rare & less common cancers.

Delighted to be part of today’s roundtable event hosted by Genomics England, alongside Cancer52 member organisations to discuss how we can collaborate to maximise the impact of #genomics for rare and less common cancers.